Advances in Cancer Immunotherapy: Annual Update

CME

Advertisement

This livestream course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field.

The course is designed to enhance learners’ competence and performance in practice and will engage learners through interactive Q&A sessions with the faculty, along with didactic presentations.

On the agenda:

  • Overview of Immunology Tolerance
  • Cellular Therapies
  • Normalizing the Tumor Microenvironment to Improve Cancer Immunotherapy: Bench to Bedside
  • Tumor Board - Immunotherapy Toxicity
  • Targeting Angiogenesis in Combination with Immune Checkpoint Inhibitors
  • Mechanisms of Resistance to Immune Checkpoint Inhibitors
  • Predictive Biomarkers of Checkpoint Blockade
  • Checkpoint Inhibitors and Multidisciplinary Care
  • Intralesional Strategies
  • Personalized Cancer Vaccines
  • Next Generation Cancer Immunotherapies
9 AMA PRA Category 1 Credits™ - maximum

9 CNE contact hours

Date

May 5-6, 2022

Location

Virtual Conference

Email

CEPrograms@hms.harvard.edu

Website

cmeregistration.hms.harvard.edu/events/advances-in-cancer-immunotherapy-annual-update/event-summary-1152b47831874eddac61b4f218dcfcbb.aspx/

Advertisement